Program -
• Doping: legislative aspects. World Anti-Doping Agency and National Anti-Doping Organisms. List of prohibited substances and methods.
• Principles of pharmacokinetics: absorption, distribution, metabolism and elimination of drugs. Pharmacokinetic parameters.
• Principles of pharmacodynamics: membrane and intracellular receptors; signal transduction pathways; drug-receptor interactions.
• Autonomic Nervous System Drugs: Parasympathetic and Sympathetic System receptors; direct sympathomimetics; beta2-agonists; beta blockers.
• Psychomotor stimulants: cocaine, amphetamines and related compounds, caffeine.
• Anabolic agents: anabolic androgenic steroids (testosterone and derivatives, designer steroids); selective androgen receptor modulators (SARM).
• Blood doping: erythropoiesis stimulating agents (ESA); agents activating the hypoxia-inducible factor (HIF); blood transfusions; artificial oxygen transporters (hemoglobin-based, perfluorocarbon-based).
• Peptide hormones and Metabolic modulators: insulins and insulin-mimetics; growth hormone (GH) and release factors; myostatin inhibitors; meldonium.
• Hormonal modulators: aromatase inhibitors; selective modulators of estrogen receptors (SERM); antiestrogens.
• Diuretics and masking agents: carbonic anhydrase inhibitors; loop diuretics; thiazides; plasma expanders; probenecid; epitestosterone.
• Anti-inflammatory drugs: natural and synthetic glucocorticoids; NSAIDs and Coxib.
• Central Nervous System drugs: opiate analgesics; benzodiazepines; cannabinoids.
• Anti-doping controls: control procedures; main methods of analysis.